Ultragenyx Pharmaceutical (RARE) Q3 2019 Earnings

1AugConfirmed
Q4 2018
Q1 2019
May 19
Q3 2019
-1.93
-1.85
-1.77
-1.69

Details

Expected EPS
-1.69
Actual EPS
-1.89
Surprise EPS
-0.2
Surprise Percent
+11.83%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -1.89 per share for Q3 2019.

0 Comments

Share your thoughts